Thursday, 18 July 2013

Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.  Such drug delivery technology by the use of injections is majorly segmented into devices and formulations, and is commonly categorized as follows:
  • Type of formulation: microspheres, liposomes, nanoparticles.
  • Type of device: needle free injectors, auto injectors, disposable syringes, reusable needles, pre-filled syringes, pen needle.
  • Type of delivery method: intravenous, intramuscular, intraperitoneal, subcutaneous.
  • Therapeutic applications: orphan diseases, auto-immune disease, oncology and others.

Some of the major factors driving the growth of injectables are increase in the number of cancer and diabetic patients globally, improved patient compliance to drug delivery system and technology advancement. Out of the all the segments of this market, the formulation technologies market occupies the major share globally due to rapid development of nanotechnologies. The key deterrents restraining the growth of global injectables market include patient safety issues, injuries caused while administering injectables, development of alternate drug delivery methods and product recalls.

The global injectable drug delivery market is dominated by North America and is followed by Europe. However the North American region lags behind European injectable market in self-injection devices due to low penetration rate of pen injectors in the U.S. The emerging Asian and Latin American countries collectively represent the fastest growing market for injectables due to the increase in incidences of cancer and diabetes in patients and also their compliance to novel technologies. Furthermore, the drug and device manufacturers are focusing on major emerging injectables market of Asia and Latin America due to less stringent regulations for acquiring approvals on devices and less competition.


Some of the key players in the injectables drug delivery technology market comprise of Becton, Dickinson and Company, Baxter International, Inc., Scandinavian Health Limited, Ypsomed Holding AG, Terumo Medical Corp., Schott AG, Owen Mumford Ltd., Antares Pharma, Inc., Eli Lilly And Company and Zogenix, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Monday, 8 July 2013


Market Research Reports According to a new market report published by Transparency Market Research "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the pharmacy automation systems market was valued at USD 4.7 billion in 2011 globally and is expected to grow to USD 7.8 billion by 2018, at a CAGR of 7.3% from 2012 to 2018.


Automated technologies in pharmacy operations result in fewer medication errors, reduced medication cost, faster delivery time and enhanced control over pharmacy inventory. These benefits are expected to drive growth throughout the forecast period. In addition, market growth is expected to accelerate due to increasing cost pressure on healthcare providers from mounting regulatory guidelines, rising number of dosage prescriptions and reducing medical reimbursements.

In 2011, the automated medication dispensing systems segment held the largest share in the global pharmacy automation systems market accounting for 48.3% and valued at USD 2.3 billion. The segment is expected to reach USD 3.6 billion by 2018 at a CAGR of 6.7% from 2012 to 2018. Shifting trend from centralized to decentralized or hybrid hospital pharmacy in large sized hospitals to improve the medication distribution process and patient safety is accelerating the demand for these systems. However, reluctance to accept these systems is seen in emerging markets due to its high deployment cost.


The majority of revenue is generated through hospital pharmacies particularly from large sized hospitals with more than 400 beds. Low budget restrains the expenditure of small and mid-sized hospitals to invest in expensive systems. Nevertheless, increasing investment is seen from these hospitals and pharmacists in affordable technologies such as tablet counters and compounding machines. The market is foreseeing considerable expansion due to growth in retail pharmacies and drug store chains in emerging countries with the introduction of FDI in these regions.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://medicalcaremarketnews.wordpress.com/



Sunday, 7 July 2013

Nanobiotechnology is an emerging field in healthcare which encompasses the applications of two fields - nanotechnology and biotechnology - in the field of healthcare and medicine. Nanotechnology is poised to become the largest competitive space in the industry with applications in several areas within the industry. Nanobiotechnology is the key to develop tools to analyze the smallest biological sample possible, which is a single molecule. This is expected to present many opportunities and expand capabilities in areas such as forensic diagnostics and forensic science. In the recent years nanotechnology has definitely moved from the drawing board and into the field with many applications in pharmaceuticals (such as drug delivery and drug discovery), agriculture, diagnostics, therapeutics, in various devices, and in robotics.


The current market is primarily led by the pharmaceutical sector with innovative technologies in drug discovery and delivery followed by diagnostics. Some of the major drivers for this market are the rising demand for minimally invasive and pain-free drug delivery, faster drug discovery, and higher sensitivity in diagnostics. As North America’s and Europe’s economic situation stabilizes, it is expected that investments and joint ventures in this domain will rise. Advances in software rendering and designing technology are also predicted to boost the growth of the market.

Demand from Asia and Latin America is also expected to propel the growth of the market. One of the restraints of the market is the prohibitively expensive manufacturing which will result in high cost of finished products. Environmental health and safety is also another concern in waste disposal along with occupational safety. Promotion of cooperation among industrial, governmental, academic, and other sectors through technological integration beyond interdisciplinary boundaries will also help drive the adoption and bring early results.

The major segmentations within the market are drug discovery, drug delivery, diagnostics, and agriculture. Broadly, the market has been classified into diagnostic and therapeutic areas. New techniques include real-time imaging, single molecule imaging, 3D imaging in live cells, bioanalytical microarrays and microfluidic devices, and biosensors with quantum dot tagging.

Some of the market players in this industry are Calando Pharmaceuticals Inc., Advectus Life Sciences, Advanced Sensor Technologies, Affymetrix, Gilead Sciences, Applied Nanotech, and Elan Pharmaceuticals and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.



Reasons for Buying this Report:

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Friday, 5 July 2013

Antithrombotic is a drug that helps reduce thrombus formation. Different antithrombotics affect different blood clotting processes like antiplatelet drugs, anticoagulants, and thrombolytic drugs. Its main application is to treat the abnormal blood in the human body. Although antithrombotic drugs are widely used to prevent and treat arterial and venous thrombosis, the disease still remains one of the major reasons for deaths across the globe. This indicates that the present drugs available are not potent enough to deal with this hazardous disease. Hence, there is tremendous potential for growth, moreover, the expiring patent of two leading drugs Plavix and Lovenox provides more potential and greater scope for the companies to emerge in this market.


The major causes of thrombosis are inactivity, blood vessel damage, medical and genetic conditions, pregnancy, obesity, and smoking. With the growing population across the globe, the demand for such life savings drugs is bound to increase. The demand for these drugs is likely to increase in the Asia Pacific region, largely due to the ever increasing population in developing economies like China and India. Although these drugs are readily available, there is not a single drug that is sufficiently effective against the disease and does not have any major side effects. Hence, there is search for newer and better drugs that are more potent and do not have any side effects. Also, there are no specific substitutes that can be used so the demand for these drugs is going to increase in the future and there is tremendous potential for growth globally.

Some of the leading companies manufacturing antithrombotic drugs are Novartis, GlaxoSmithKline, Bayer International and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report:
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Wednesday, 3 July 2013

Medical Simulation is a branch of science technology which is used to educate and train the medical professionals about surgeries, prescriptions and general surgeries. These are also used to train students in anatomy and physiology during their clinical trainings. The end users of the medical simulation technology markets are academics, military, hospitals and others.

According to the Institute of Medicine, around 44,000 to 98,000 deaths occur annually worldwide due to medical errors during patient treatment. To reduce these errors medical simulation is used extensively as it increases the patient’s safety. Patient safety coupled with technological advancement is driving the use of medical simulation. Other factors which propel the growth include increase in health care cost and rise in demand of minimal invasive treatments. High cost of simulators is persists to be an obstacle for the growth of this market along with availability of fewer funds.

Medical Simulation uses the haptic and virtual and reality technology. Haptic technology works on the senses of touch by applying forces, vibration and the motions and assists in realistic, multisensory learning to the medical students and healthcare professionals while virtual and reality technology uses computer simulated environment to simulate the physical presence in both, the real world as well as imaginative world . It helps surgeons to learn surgery without actual use of patients. This thus reduces the risks of patients and also helps to train the surgeons for new surgical procedures Products and services of simulation markets includes Computed Tomography, Magnetic Resonance Imaging, high fidelity mannequins, live environments, simulated clinical environment, serious game, Positron Emission Tomography, fidelity trainers, performance recording, imaging simulation, IV simulators, second life, interventional simulators, cardiovascular simulators, mid/low simulator, ultrasound imaging, surgical simulators and healthcare/medical simulation training services. Largest market for the healthcare/medical simulation is North America followed by Europe and Asian region. China and India are expected to be the booming market for the same industry in near future.

Some of the major players in the healthcare/medical simulation market include B-Line Medical, LLC, 3B Scientific GmbH, CAE Ltd., Anesoft Corporation and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World
This report provides comprehensive analysis of 
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments.

Wednesday, 26 June 2013

The U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012 and is further expected to reach USD 17.4 billion by 2018, growing at a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies about 80% of the U.S. vaccine market.

Browse Report : U.S. human vaccine market

U.S. will continue to lead the global vaccine market due to rising prevalence of infectious diseases in humans and animals, and advancement in biotechnology in the region. Short functional shelf life of certain vaccines will have negative impact on the market growth, but huge product pipeline of the multinational firms will overcome this concern and will drive the future growth of the market.

Pediatric vaccine segment in the U.S. human vaccine market enjoys high share as well as high growth rate due to government compulsion for child immunization. Adult & adolescent vaccine market is expected to grow moderately over the next six years due to rising awareness and increasing vaccination for human papillomavirus (HPV) and such other viral diseases.
Livestock vaccine is the leading segment of the overall U.S. animal vaccine market accounting for 58.1% in 2012 due to more organized dairy sector and increased awareness towards prevention of infectious diseases in cattle. Bovine vaccine market is the largest revenue generating segment of the overall Livestock vaccine market in 2012 due to rising vaccination to protect breeding animals against infectious diseases. Together feline vaccine and canine vaccine accounted for about 95.1% of the overall U.S. companion animal vaccine market in 2011.

In 2011, overall leading producers of human vaccine for the U.S. market were Sanofi-Aventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture and Novartis. The leading producers of animal vaccine for the U.S. market includes Pfizer Animal Health, Merial (Sanofi-Aventis), Intervet/Schering-Plough (Merck) and Novartis Animal Health.

This report helps to identify factors, which will be the driving force behind the U.S. Vaccine market and sub-markets in the next six years. The report provides extensive analysis of the U.S. vaccine market, current market trends, industry drivers and challenges for better understanding of the U.S. vaccine market structure. The report has segregated the U.S. vaccine industry in terms of its product type. Annual estimates and forecasts are provided for the period 2012 through 2018 in terms of value in USD million.

Segments Analyzed
U.S. vaccine market- by Product
  • Human vaccine
    • Pediatric Vaccines
    • Adult & Adolescent vaccine
    • Other human vaccine
  • Animal vaccine
    • Livestock vaccine
      • Bovine vaccine
      • Porcine vaccine
      • Ovine vaccine
    • Companion animal vaccine
      • Feline vaccine
      • Canine vaccine
      • Equine vaccine
    • Other animal vaccine



Tuesday, 25 June 2013

Innovations and product development, enhanced product properties such as strength and durability, growth and advancement of the global automotive industry are the major factors that have been driving the market for technical textiles. The major drawbacks faced by the market are higher cost of finished products affecting end user industry pricing characteristics and huge fragmentation of the existing market. 

Browse Report : Technical Textiles Market 

This research study provides a comprehensive analysis of the technical textiles industry on a global as well as regional level. The report identifies drivers, restraints and opportunities in the global technical textiles market and renders an extensive analysis of the industry, current trends and segmentation for a better understanding of the market structure. The report segments the technical textiles market on the basis of various technologies used in the manufacturing process, end user industry segments and key regions along with detailed segmentation and analysis within the regions.

This report by Transparency Market Research analyzes the technical textiles market from a global perspective and endeavors to portray a detailed and comprehensive collection of data and its analysis on the basis of various market parameters. The report also strives to compile together a macroscopic view of the complete demand and supply characteristics of technical textiles by providing historical data from 2009 and a forecast of market segmentation until 2018 along with detailed analyses of revenues and volumes.

Technical textiles are slightly modified, high performance textiles that are used for their special properties and functionality. With an increasing application base in various end-user industries such as healthcare, agriculture, construction, clothing, packaging, sportswear and sports equipment, automotives, environment protection and other such areas, the demand for technical textiles has increased significantly over the past few years and is expected to keep expanding over the coming years. The technical textiles market is believed to be one of the most innovative branches of industry across the world and has been reported to be among the top five technology-intensive markets with a great potential for advancement.

The most important factor governing market attractiveness is the versatility of a product and this plays a major role in the advancement of technical textiles. In many regions across the world, the market for basic textiles is believed to have reached a stage of maturity and this has in turn reflected on the technical textile market. Emerging economies such as China and India have been laying huge emphasis on adopting the latest technologies and production processes in different industry segments. The primary reason for the tremendous success of technical textiles is the potential for innovation using woven, knitted and nonwoven fabrics either individually or more importantly, as a combination with each other.

Technical textiles are manufactured from yarn, fiber and filaments using various technologies such as thermoforming, three dimensional weaving, three dimensional knitting, nanotechnology, heat-set methods, finishing treatments, hand-made methods and others. Of these, thermoforming, three dimensional weaving and three dimensional knitting are the most widely used methods while nanotechnology has a huge scope for expansion.

Based on the end user industry where technical textiles are used, the market has been segmented into eleven categories such as Mobiltech, Indutech, Sportech, Buildtech, Hometech, Clothtech, Meditech, Agrotech, Protech, Packtech and others. These categories cover the entire range of technical textiles that are manufactured in today’s market and present a bright future with constantly improving technology and products.

Traditionally, North America and Europe have been the major markets for technical textiles in the past but in recent years, the sheer volume of demand from Asia Pacific has eclipsed the global demand for technical textiles. With better technology capabilities, ever increasing demand from different end user industries and a favorable support structure from various governments, technical textiles are expected have a huge market to cater to globally. This report provides regional analysis and splits of both technology as well as end user industries in various regions across the world.

The report also aims to provide a detailed analysis of market revenue shares of companies such as Freudenberg & Co. KG, DuPont, Kimberly-Clark Corporation, Ahlstrom Corporation and a number of other players including Fiberweb PLC, Polymer Group Inc., Companhia ProvidĂȘncia, Johns Manville and the TWE Group.

The report also includes a detailed value chain of the market along with a Porter’s Five Forces analysis to identify market dynamics for all upstream and downstream segments thus enabling a strategy-making process for buyers of technical textiles, suppliers of raw materials, substitutes, and potential new entrants into the market based on possibility of forward or backward integration into the various business segments. The report also presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the technical textiles market as below:

Technical textiles market: Technology analysis
  • Thermo-forming
  • Three Dimensional Weaving
  • Three Dimensional Knitting
  • Fabrics Produced Using Nanotechnology
  • Heat-set Synthetics
  • Finishing Treatments (such as Water-resistant Coatings & Holographic Laminates)
  • Hand-made elements (such as Stitch or Applique)
  • Others
Technical textiles market: End user analysis
  • Mobiltech
  • Indutech
  • Sportech
  • Buildtech
  • Hometech
  • Clothtech
  • Meditech
  • Agrotech
  • Protech
  • Packtech
  • Others (Oekotech and Geotech)
Technical textiles have also been segmented by geography and further divided by technology and end user in terms of both volumes and revenues in their respective regions.

Technical textiles market: Regional analysis

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)